Tykerb approved

The US FDA announced today that the drug Tykerb has been approved for women with HER2+ tumors that have continued growing despite chemotherapy and use of the drug Herceptin.

Head over to the Glaxo (GlaxoSmithKline) home page to read more about what this pharmaceutical firm came up with to give hope to women with advanced/metastatic breast cancer.

Glaxo has also expanded their patient assistance program to include Tykerb ... a program that provides low income patients with access to their oncology products. Nice going GSK!

Here's the American Cancer Society Press Release on the approval of GSK's Tykerb: ACS :: New Drug Approved for Breast Cancer.

This Tykerb home page is coming soon ...